Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The object of this study was to evaluate the effect of a high-dose ethylester concentrate of
of n-3 fatty acids administered early after an acute myocardial infarction on subsequent
cardiac events and serum lipids.The second purpose of this study was to assess the impact of
high-dose n-3 fatty acids on several markers of coagulation, inflammation, endothelial
dysfunction and lipid peroxidation. Re-investigation was intended after a prolonged
wash-out-period.
Phase:
Phase 3
Details
Lead Sponsor:
Helse Stavanger HF
Collaborators:
Pharmacia and Upjohn Pronova BioPharma University of Bergen University of Oslo
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E